Versor Investments’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,100
Closed -$365K 413
2025
Q4
$365K Sell
24,100
-10,600
-31% -$162K 0.06% 415
2025
Q3
$508K Buy
34,700
+13,067
+60% +$172K 0.09% 312
2025
Q2
$241K Buy
21,633
+8,133
+60% +$101K 0.04% 609
2025
Q1
$220K Sell
13,500
-15,100
-53% -$265K 0.04% 637
2024
Q4
$499K Buy
+28,600
New +$497K 0.09% 389
2023
Q4
Sell
-14,500
Closed -$186K 819
2023
Q3
$186K Buy
+14,500
New +$261K 0.04% 598

Other funds holding OFIX

Versor Investments's OFIX Position: Q1 2026 in Review

Versor Investments sold out of Orthofix Medical (OFIX) in Q1 2026, closing a stake of 24,100 shares — an estimated $365K sold.

Versor Investments first reported a position in OFIX in Q3 2023 and held it in 6 quarters. The position peaked at $508K in Q3 2025. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Versor Investments reported no remaining Orthofix Medical position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 24,100 Orthofix Medical shares in Q1 2026, an estimated $365K.
  • Versor Investments first reported a position in Orthofix Medical in Q3 2023 and held it in 6 quarters.
  • Versor Investments's Orthofix Medical position peaked at $508K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.